Kimberly Gail Dicuccio Heckert MD
Neurorehabilitation, Brain Injury Medicine
Physician
Join to view full profile
130 S 9th StPhiladelphia, PA 19107
Phone+1 215-606-4888
Fax+1 215-923-6808
Dr. Heckert is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Medicine and Dentistry of New JerseyStroke & Brain Injury Rehabilitation, 2007 - 2008
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Physical Medicine and Rehabilitation, 2004 - 2007
UPMC Medical Education (Mercy)Internship, Transitional Year, 2003 - 2004- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003
Certifications & Licensure
NJ State Medical License 2006 - 2027
PA State Medical License 2003 - 2026
NY State Medical License 2008 - 2010
American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation- American Board of Physical Medicine and Rehabilitation Brain Injury Medicine
Publications & Presentations
PubMed
- 1 citationsDelphi Analysis: Optimizing Anatomy Teaching and Ultrasound Training for Botulinum Neurotoxin Type A Injection in Spasticity and Dystonia.Kimberly Heckert, Bo Biering-Sørensen, Tobias Bäumer, Omar Khan, Fernando Pagan
Toxins. 2024-08-21 - 9 citationsThe Dearth of Disability Medical Education and a Partial Solution.Michael D Stillman, Michael Mallow, Nethra Ankam, Jason Ojeda, Mary Stephens
Teaching and Learning in Medicine. 2022-09-09 - 1 citationsAtypical Presentation of Myotonic Dystrophy Type 1Kimberly DiCuccio Heckert, Robert S. Skerker
PM & R. 2011-04-01
Press Mentions
JAMA Dermatology Publishes Data Showing RINVOQ® (Upadacitinib) Achieved Superiority Versus DUPIXENT® (Dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic DermatitisAugust 4th, 2021- Botox Approved to Treat Spasticity in 8 New Arm, Hand MusclesAugust 2nd, 2021
- AbbVie (ABBV) Announces FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb SpasticityJuly 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
